A Phase I Study of MSB2311 in Advanced Solid Tumors
Clinical trial NCT03463473 · COMPLETED
Trial details
- NCT number
- NCT03463473
- Sponsor
- Suzhou Transcenta Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2020-06-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.